-
Nektar Therapeutics (NASDAQ:NKTR) Given Buy Rating at HC Wainwright
Источник: Buzz FX / 14 мар 2025 07:36:17 America/Chicago
Nektar Therapeutics (NASDAQ:NKTR) Given Buy Rating at HC Wainwright Written by MarketBeat March 14, 2025 Share Link copied to clipboard. Remove Ads Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) 's stock had its "buy" rating restated
Read more...